Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge (2026-08-05)
Eli Lilly now expects 2026 revenue to come in between $85 billion and $87 billion, up from previous guidance of $82 billion to $85 billion.